LatAmGrowth SPAC (LATG) Adjourns Early Liquidation Vote

proxy vote

LatAmGrowth SPAC (LATG) Adjourns Early Liquidation Vote

LatAmGrowth SPAC (NASDAQ:LATG) announced in an 8-K that it adjourned its special meeting yesterday to liquidate early and will reconvene it at 2 pm ET September 28.

The proposals on its ballot would have initiated the process of winding down the SPAC and returning all trust capital to investors outside of $100,000 for dissolution expenses.

...READ MORE
latest-news

The Latest SPAC News and Rumors: September 21, 2023


Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 


JSE reviewing listing requirements with aim to simplify them

The Johannesburg Stock Exchange will be reviewing all its listings requirements with the objective of further simplifying its requirements, as part of its ongoing efforts to create an enabling listing environment and attract local and international listings.

...READ MORE

Nabors Energy Transition Corp. (NETC) and Vast Add $10M Equity Commitment to Deal

Nabors Energy Transition Corp. (NYSE:NETC) announced this morning that Vast has added an equity commitment of up to $10 million to its combination with concentrated solar power producer Vast.

The new commitment comes at $10.20 per share from the Canberra Airport Group and half of it is to come up front at close.

...READ MORE
murphy canyon

Murphy Canyon (MURF) Shareholders Approve Conduit Deal

Murphy Canyon Acquisition Corp. (NASDAQ:MURF) announced this afternoon that its stockholders voted in favor of the proposed business combination with Conduit Pharmaceuticals Limited (“Conduit”).

Details on the vote, along with redemption numbers, have not been filed yet, but the Company expects the closing to occur as soon as practicable, subject to the satisfaction or waiver of remaining closing conditions.

...READ MORE
latest liquidations

TradeUP Acquisition Corp. (UPTD) Signs Additional Subscription Agreements Ahead of Close

TradeUP (NASDAQ:UPTD) announced in an 8-K this afternoon that has entered into additional subscription agreements in connection with its combination with Estrella Biopharma.

Under these subscription agreements, Plentiful Limited and Lianhe World Limited, collectively known as the “Investors”, agreed to each buy $5,000,000 worth of UPTD’s common stock, priced at $10.00 per share. 

...READ MORE
latest-news

Digital Transformation Opportunities (DTOC) Shareholders Approve American Oncology Deal

Digital Transformation (NASDAQ:DTOC) announced in an 8-K this morning that its shareholders approved its business combination with physician network American Oncology at a special meeting yesterday.

The two sides later announced they have closed the transaction and the combined company will begin trading on the Nasdaq under the symbol “AONC” on September 21.

...READ MORE
proxy vote

Hennessy Capital Investment Corp VI (HCVI) Re-Schedules Extension with Non-Redemption Pact

Hennessy Capital Investment Corp VI (NASDAQ:HCVI) announced in an 8-K filing this morning that it will push its September 27 extension vote to 9 am ET September 29.

Shareholders will now have until 5 pm ET September 27 to make their final redemption decisions and owners of 132,398 shares have decided to stay in as a part of a non-redemption agreement Hennessy VI also announced in the filing.

...READ MORE
proxy vote
latest-news
agreements

Golden Star Acquisition Corporation (GODN) to Combine with Gamehaus in $500M Deal

Golden Star (NASDAQ:GODN) has entered into a definitive agreement to combine with gaming company Gamehaus at an enterprise value of $500 million. Shanghai-based Gamehaus helps small and medium-sized mobile game developers get their games published and marketed with data tools and direct capital investments. The combined company is expected to trade on the Nasdaq once
Read More
To access this post, you must purchase 1 - User: Monthly Plan.
latest-news

Graf Acquisition Corp. IV (GFOR) Adds $10M in Note Funding to NKGen Biotech Deal

Graf Acquisition Corp. IV (NYSE:GFOR) announced in an 8-K this morning that it has added $10 million in convertible note funding to its combination with NKGen Biotech.

NKGen’s majority shareholder NKMax (KOSDAQ:182400) has put up the cash for the move and in exchange the notes are to bear interest payable at either a 5% rate in cash or 8% in stock.

...READ MORE